Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05FKU
|
|||
| Drug Name |
ETC-1922159
|
|||
| Synonyms |
Etc-159; ETC-159; UNII-5L854240DQ; 1638250-96-0; CHEMBL3633802; 5L854240DQ; SCHEMBL17626176; MolPort-044-728-903; KS-00000TT9; BDBM50133866; ZINC175660737; AKOS030526630; CS-5162; 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide; HY-18988; 2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Biomedical Sciences Institute SingaporeD3 (Drug Product and Development) Singapore
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17N7O3
|
|||
| Canonical SMILES |
CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)NC3=NN=C(C=C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27)
|
|||
| InChIKey |
QTRXIFVSTWXRJJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1638250-96-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein-serine O-palmitoleoyltransferase porcupine (PORCN) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.